A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples